ArticleScientific reports2022

Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo.

Maohua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.